Yield10 Bioscience Inc
NASDAQ:YTEN
Yield10 Bioscience Inc
Change in Deffered Taxes
Yield10 Bioscience Inc
Change in Deffered Taxes Peer Comparison
Competitive Change in Deffered Taxes Analysis
Latest Figures & CAGR of Competitors
Company | Change in Deffered Taxes | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Yield10 Bioscience Inc
NASDAQ:YTEN
|
Change in Deffered Taxes
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Change in Deffered Taxes
-$2.9B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Change in Deffered Taxes
-$962m
|
CAGR 3-Years
-69%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-21%
|
|
Amgen Inc
NASDAQ:AMGN
|
Change in Deffered Taxes
-$1.6B
|
CAGR 3-Years
-77%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Change in Deffered Taxes
-$536.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
19%
|
CAGR 10-Years
-7%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Change in Deffered Taxes
-$811.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-41%
|
CAGR 10-Years
N/A
|
See Also
What is Yield10 Bioscience Inc's Change in Deffered Taxes?
Change in Deffered Taxes
0
USD
Based on the financial report for Dec 31, 2023, Yield10 Bioscience Inc's Change in Deffered Taxes amounts to 0 USD.